Sayit Mahmut Erdogan

Phone+4535331653
Emailsayit.erdogansund.kudk
Websitehttps://cmp.ku.dk/, https://isim.ku.dk/dansk/

Blegdamsvej 3B, 2200 København N
Blegdamsvej 3B
2200 København N

Research activity per year

121 Citations
3 Journal article

First-in-human use of a modular capsid virus-like vaccine platform: An open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
Smit, M. J., Sander, A. F., Ariaans, M. B. P. A., Fougeroux, C., Heinzel, C., Fendel, R., Esen, M., Kremsner, P. G., Ter Heine, R., Wertheim, H. F., Idorn, M., Paludan, S. R., Underwood, A. P., Binderup, A., Ramirez, S., Bukh, J., Soegaard, M., Erdogan, S. M., Gustavsson, T., Clemmensen, S. & 14 others, Theander, T. G., Salanti, A., Hamborg, M., de Jongh, W. A., McCall, M. B. B., Nielsen, M. A., Mordmüller, B. G., COUGH-1 trial study group, Dagil, R., Goksøyr, L., Hulen, T. M., Brygger, C. M. J., Khalifé, P. K. & Vidal-Calvo, E. E., 2023, In: The Lancet Microbe. 4, 3, p. e140-e148
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File

19 Citations (Scopus)

57 Downloads (Pure)
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
Fougeroux, C., Goksøyr, L., Idorn, M., Soroka, V., Myeni, S. K., Dagil, R., Janitzek, C. M., Søgaard, M., Aves, K-L., Horsted, E. W., Erdogan, S. M., Gustavsson, T., Dorosz, J., Clemmensen, S., Fredsgaard, L., Thrane, S., Vidal-Calvo, E. E., Khalifé, P., Hulen, T. M., Choudhary, S. & 27 others, Theisen, M., Singh, S. K., Garcia-Senosiain, A., Van Oosten, L., Pijlman, G., Hierzberger, B., Domeyer, T., Nalewajek, B. W., Strøbæk, A., Skrzypczak, M., Andersson, L. F., Buus, S., Buus, A. S., Christensen, J. P., Dalebout, T. J., Iversen, K., Harritshøj, L. H., Mordmüller, B., Ullum, H., Reinert, L. S., de Jongh, W. A., Kikkert, M., Paludan, S. R., Theander, T. G., Nielsen, M. A., Salanti, A. & Sander, A. F., 2021, In: Nature Communications. 12, 1, p. 324
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File

94 Citations (Scopus)

227 Downloads (Pure)
Development of a bispecific immune engager using a recombinant malaria protein
Nordmaj, M. A., Roberts, M. E., Sachse, E. S., Dagil, R., Andersen, A. P., Skeltved, N., Grunddal, K. V., Erdoğan, S. M., Choudhary, S., Gustavsson, T., Ørum-madsen, M. S., Moskalev, I., Tian, W., Yang, Z., Clausen, T. M., Theander, T. G., Daugaard, M., Nielsen, M. A. & Salanti, A., 2021, In: Cell Death & Disease. 12, 4, 11 p., 353.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File

8 Citations (Scopus)

59 Downloads (Pure)

Sayit Mahmut Erdogan

Collaborations and top research areas from the last five years

Dive into details

First-in-human use of a modular capsid virus-like vaccine platform: An open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

Development of a bispecific immune engager using a recombinant malaria protein

Sayit Mahmut Erdogan

Collaborations and top research areas from the last five years

Research output

First-in-human use of a modular capsid virus-like vaccine platform: An open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

Development of a bispecific immune engager using a recombinant malaria protein